| GENE_SYMBOL |
HGNC_ID |
UNIPROT_ID |
DRUG_NAME |
PUBCHEM_CID |
Datasource |
| ADRA2A |
HGNC:281 |
P08913 |
4-[2-[4-(4,5-Dichloro-2-methoxyphenyl)piperazin-1-yl]ethyl]-11-methyl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),5-trien-3-one |
44405726 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
4-[2-(4-Isoquinolin-8-ylpiperazin-1-yl)ethyl]-11-methyl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),5-trien-3-one |
44405730 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
6-(4-methoxyphenyl)-3-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione |
44405930 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
6-(2-methoxyphenyl)-3-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione |
44405935 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
3-(2-(4-(2-chlorophenyl)piperazin-1-yl)ethyl)-6-phenyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione |
44405965 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
3-(2-(4-(2-chlorophenyl)piperazin-1-yl)ethyl)-6-(2-methoxyphenyl)-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione |
44405980 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
6-(2-chlorophenyl)-3-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione |
44405981 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
6-(2-chlorophenyl)-3-(2-(4-(2-chlorophenyl)piperazin-1-yl)ethyl)-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione |
44405985 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
3-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)-6-o-tolyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione |
44405991 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
3-(2-(4-(2-chlorophenyl)piperazin-1-yl)ethyl)-6-o-tolyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione |
44405995 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
3-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)-6-p-tolyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione |
44406002 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
3-[2-[4-(2-chlorophenyl)-1-piperazinyl]ethyl]-6-(4-methylphenyl)-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione |
44406003 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
6-(4-chlorophenyl)-3-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione |
44406012 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
3-(2-(4-(2-chlorophenyl)piperazin-1-yl)ethyl)-6-(4-methoxyphenyl)-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione |
44406077 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
(R)-3-((4-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)methyl)piperidin-1-yl)methyl)-7,9-dihydro-2H-[1,4]dioxino[2,3-e]indol-8(3H)-one |
46888928 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
(R)-3-((4-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)piperidin-1-yl)methyl)-7,9-dihydro-2H-[1,4]dioxino[2,3-e]indol-8(3H)-one |
46888985 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
N-(3-(2-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)piperidin-1-yl)ethoxy)phenyl)methanesulfonamide |
46888986 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
N-(2-fluoro-5-(2-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)piperidin-1-yl)ethoxy)phenyl)methanesulfonamide |
46889013 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
(3R)-3-((3-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)methyl)-8-azabicyclo[3.2.1]octan-8-yl)methyl)-7,9-dihydro-2H-[1,4]dioxino[2,3-e]indol-8(3H)-one |
46889014 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
(R)-7-[8-(2-Oxo-1,2,3,4-tetrahydro-quinolin-7-ylmethyl)-3-aza-bicyclo[3.2.1]oct-3-ylmethyl]-7,8-dihydro-3H-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalen-2-one |
46889015 |
TTD |